OBN Digital Event 'Maximising Opportunities for Life Sciences Post Brexit'
Event Start Date: Wednesday, May 27, 2020 8:00 AM
Event End Date: Wednesday, May 27, 2020 8:00 PM
There is no doubt that the UK’s departure from the EU will provide both opportunities and challenges in many areas of an organisations’ operation. In regard to life sciences, this will be most keenly seen in areas such as access to funding, talent, movement of goods, regulatory activity and clinical trials.
This event will feature three experts from the fields of funding, regulatory and legal, who will provide an update on where the new opportunities are for the industry.
We will be collating questions for all speakers in advance of the event, so if you have a burning question that you would like to ask, please send to email@example.com by 9am on 19 May.
Event Host: Oliver Pumfrey, Managing Director, FTI Consulting
Keynote one: Carole Pugh, Managing Director, EUDRAC - will provide an update on the post Brexit regulatory framework, including what these new regulations mean for life sciences innovation, how it will help to accelerate research and ultimately benefit patients
Keynote two: James Tumbridge, Partner, Barrister, Venner Shipley - will provide an update on how changes in IP legislation and bureaucracy post Brexit can create opportunities for the industry
Keynote three: Shawn Manning, Managing Director, Akesios Associates - will provide an update on the life sciences funding landscape post Brexit. What changes might we expect and what will be the likely impact to the existing UK ecosystem?